SCHEMBL7920593

SCHEMBL7920593

CNCc1ccc2cccnc2n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 1/20 0.45
ALDH1A1 P00352 1/20 0.43
SUCNR1 Q9BXA5 7/20 0.42
KDM4E B2RXH2 2/20 0.42
LMNA P02545 2/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
PDE10A Q9Y233 3/20 0.41
GMNN O75496 1/20 0.38
TP53 P04637 1/20 0.38
HSP90AA1 P07900 1/20 0.38
MMP2 P08253 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
MAPT P10636 1/20 0.38
MMP9 P14780 1/20 0.38
ALOX15 P16050 1/20 0.38
TSHR P16473 1/20 0.38
NFKB1 P19838 1/20 0.38
MMP8 P22894 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4823229 0.81 ALDH1A1 (0.48) ALDH1A1SUCNR1KDM4ELMNAMEN1
SCHEMBL22824076 0.81 CCR1 (0.55) CYP2A6ALDH1A1KDM4ELMNAPDE10A
SCHEMBL20481012 0.80 SUCNR1 (0.47) ALDH1A1SUCNR1LMNAPDE10AALOX15
SCHEMBL12895009 0.78 PDE10A (0.49) ALDH1A1SUCNR1KDM4ELMNAMEN1
SCHEMBL2009161 0.76 CCR1 (0.48) ALDH1A1SUCNR1KDM4ELMNAMEN1
SCHEMBL3275331 0.76 KDM4E (0.50) ALDH1A1SUCNR1KDM4ELMNAMEN1
SCHEMBL7514147 0.76 ALDH1A1 (0.47) ALDH1A1SUCNR1KDM4ELMNAMEN1
SCHEMBL19952703 0.76 ALDH1A1 (0.47) ALDH1A1SUCNR1KDM4ELMNAMEN1
SCHEMBL24417903 0.75 ALDH1A1 (0.43) ALDH1A1SUCNR1KDM4ELMNAMEN1
SCHEMBL22104646 0.75 ALDH1A1 (0.43) ALDH1A1SUCNR1KDM4ELMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6232308-B1 USEFUL FOR INHIBITING BONE RESORPTION, TREATING AND PREVENTING OSTEOPOROSIS, INHIBITING VASCULAR RESTENOSIS, DIABETIC RETINOPATHY, MACULAR DEGENERATION, AND ANGIOGENESIS MERCK & CO., INC. 2001-05-15 US disclosed